Literature DB >> 15381374

Deletion of CBFB in a patient with acute myelomonocytic leukemia (AML M4Eo) and inversion 16.

Nicole Egan1, John O'Reilly, Lucia Chipper, Melinda Higgins, Richard Herrmann, Paul Cannell.   

Abstract

Acute myelomonocytic leukemia with bone marrow eosinophilia (AML M4Eo) is a subtype of AML with distinct morphological features. Inversion (16)(p13.1q22), t(16;16)(p13.1;q22), and del(16)(q22) are nonrandom abnormalities associated with AML M4Eo and a favorable prognosis, compared with the standard risk group for AML. Deletions of the proximal region of the MYH11 gene located at 16p13.1 have been detected in about 20% of patients with inv(16), with an undetermined effect on patient survival. We present the case of a patient with AML M4Eo and inversion 16 with a distal deletion of the CBFB gene at 16q22 detected with fluorescence in situ hybridization. To our knowledge, only one previous report of a similar deletion has appeared in the literature.

Entities:  

Mesh:

Year:  2004        PMID: 15381374     DOI: 10.1016/j.cancergencyto.2004.01.022

Source DB:  PubMed          Journal:  Cancer Genet Cytogenet        ISSN: 0165-4608


  2 in total

1.  Acute myeloid leukemia with inv(16)(p13.1q22) and deletion of the 5'MYH11/3'CBFB gene fusion: a report of two cases and literature review.

Authors:  Lili Lv; Jingwei Yu; Zhongxia Qi
Journal:  Mol Cytogenet       Date:  2020-01-30       Impact factor: 2.009

2.  Identification of a cryptic submicroscopic deletion using a combination of fluorescence in situ hybridization and array comparative genomic hybridization in a t(3;5)(q25;q35)-positive acute myeloid leukemia patient: A case report and review of the literature.

Authors:  Man Gao; Shibo Li; Lina Wang; Shu Nie; Hui Pang; Xianglan Lu; Xianfu Wang; Mingwei Wang; Shirong Guo; Yuhan Ma; Fanzheng Meng
Journal:  Medicine (Baltimore)       Date:  2020-10-23       Impact factor: 1.817

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.